data_6dzc_residue ############################ # Computer software used # ############################ save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 6dzc _Structure_validation_residue.Date_analyzed 2019-05-10 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.514 ' H ' ' C ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER 56.0 -166.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.695 0.283 . . . . 0.0 110.419 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 2' ' ' SER . 36.6 mtp180 55.48 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.519 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.53 117.71 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 6' ' ' ARG . 11.3 t80 173.52 125.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -56.83 134.21 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.867 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.54 71.16 1.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.413 0.625 . . . . 0.0 110.874 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.541 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 10.47 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.21 1.94 . . . . 0.0 112.11 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.541 ' H ' ' C ' ' A' ' 8' ' ' DPR . 12.4 tttp -165.34 149.07 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.462 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.2 pp -143.62 131.47 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 mm -111.45 153.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.272 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -163.73 141.61 7.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 15' ' ' GLU . 15.5 m120 -164.54 -17.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.15 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ASN . 4.7 tp10 33.0 40.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.504 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.514 ' C ' ' H ' ' A' ' 2' ' ' SER . 13.9 tpp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.398 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -164.63 78.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.608 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.551 HH11 ' CG2' ' A' ' 12' ' ' ILE . 9.2 ttp180 -172.26 125.62 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.567 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.12 176.81 35.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.423 ' CG ' ' N ' ' A' ' 6' ' ' ARG . 63.1 t80 -173.14 164.9 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 5' ' ' PHE . 17.0 ttm-85 -120.21 126.67 51.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.54 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.18 73.85 1.51 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.602 0.715 . . . . 0.0 110.485 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 11.64 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.259 1.972 . . . . 0.0 112.603 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.54 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -161.6 151.59 16.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.57 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.19 146.46 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.331 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.551 ' CG2' HH11 ' A' ' 3' ' ' ARG . 22.3 mm -103.11 134.13 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.453 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 175.71 143.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.55 134.74 19.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.52 55.62 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.543 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.568 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -149.63 60.09 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.464 HH21 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mtt-85 -143.72 134.34 24.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.49 167.66 35.77 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -168.09 159.8 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 110.422 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 124.51 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.343 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -135.16 73.71 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.291 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.466 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.98 11.1 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.3 2.0 . . . . 0.0 112.564 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' PHE . 40.6 tttt -160.71 149.55 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -147.68 147.98 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.06 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -102.26 144.56 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -166.24 162.48 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.626 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.2 -174.24 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.45 -14.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.475 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -52.95 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.532 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.672 ' N ' HD22 ' A' ' 14' ' ' ASN . 15.6 mtp180 -137.78 20.83 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.665 ' N ' HD22 ' A' ' 14' ' ' ASN . . . 56.65 159.11 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -173.0 168.03 4.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.32 124.65 39.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.673 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 73.42 1.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.621 0.724 . . . . 0.0 110.642 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.469 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.27 9.31 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.189 1.926 . . . . 0.0 112.295 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.0 tttm -153.95 150.58 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.39 145.18 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.267 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.4 mm -107.03 159.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 tpt180 -132.11 -149.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.672 HD22 ' N ' ' A' ' 3' ' ' ARG . 15.8 m120 -148.16 144.63 27.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -179.88 6.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.132 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.1 tpt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 -179.882 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.633 ' C ' ' CA ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 1.446 ' HA ' ' CA ' ' A' ' 2' ' ' SER 0.832 1.6 m -40.98 -123.85 0.0 OUTLIER 'General case' 2 CA--C 0.992 -20.492 1 CA-C-O 128.647 4.07 . . . . 0.0 119.715 163.677 . . . . . . . . 5 3 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -120.94 122.51 40.34 Favored 'General case' 0 C--N 1.328 -0.333 1 CA-C-N 108.069 -4.15 . . . . 0.0 110.093 -177.968 . . . . . . . . 4 4 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.7 120.19 0.8 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 6' ' ' ARG . 8.5 t80 168.4 124.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.671 0.272 . . . . 0.0 110.671 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -55.55 137.17 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -136.77 71.33 1.41 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.517 0.675 . . . . 0.0 110.837 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.479 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.04 9.99 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.303 2.002 . . . . 0.0 112.275 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.7 ttmt -161.37 151.16 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.4 pp -139.8 130.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.182 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 26.1 mm -106.73 161.29 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.045 179.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 15.9 ttm180 -164.89 143.17 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.65 -179.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.53 ' ND2' ' O ' ' A' ' 3' ' ' ARG . 0.1 OUTLIER -144.67 -121.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.439 ' H ' ' CG ' ' A' ' 14' ' ' ASN . 5.1 tm-20 -159.27 0.01 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.835 -179.985 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 2.5 tpt180 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -136.42 25.86 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.72 0.295 . . . . 0.0 110.54 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.94 148.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.06 160.27 23.83 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE1' ' O ' ' A' ' 6' ' ' ARG . 73.2 t80 -147.17 157.75 43.71 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.725 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 9.6 ttm180 -116.32 138.8 51.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.016 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 72.83 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 110.466 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.466 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.65 12.48 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.098 1.865 . . . . 0.0 112.164 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.563 ' HZ3' ' CG1' ' A' ' 12' ' ' ILE . 15.7 tttm -153.56 151.44 29.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 0.0 110.667 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 143.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.96 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . 0.571 ' N ' ' CD1' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -134.16 112.95 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' CG ' ' N ' ' A' ' 14' ' ' ASN . 11.5 ttm180 -153.2 154.13 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.533 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.674 ' ND2' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -116.29 -168.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.381 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 57.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.439 ' CB ' HD22 ' A' ' 14' ' ' ASN . 0.3 OUTLIER -63.15 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.7 0.286 . . . . 0.0 110.475 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.9 ttm180 -102.75 -25.65 13.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.161 0.505 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 3' ' ' ARG . . . 53.53 166.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -172.83 164.03 5.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 128.32 55.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.41 72.06 1.41 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.637 0.732 . . . . 0.0 110.573 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.491 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.98 10.94 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.234 1.956 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' PHE . 27.8 tttt -163.57 150.94 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 146.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -99.19 134.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 174.22 143.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -162.99 128.2 3.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.477 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 5.2 mp0 41.66 -93.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' ASN . 14.5 ttm-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.545 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 78.0 39.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -136.99 143.5 42.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.581 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 -178.49 35.33 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE1' ' CE2' ' A' ' 7' ' ' PHE . 7.9 t80 -173.28 118.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.21 124.25 31.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' CE2' ' CE1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -133.34 75.74 1.63 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.195 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.484 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.03 11.0 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.217 1.945 . . . . 0.0 112.586 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.491 ' O ' ' N ' ' A' ' 7' ' ' PHE . 34.8 tttt -155.88 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.05 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.265 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.11 136.8 44.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.206 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 176.28 143.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -127.07 -133.88 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -168.09 45.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.683 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -75.92 -123.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.729 0.3 . . . . 0.0 110.563 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -122.44 139.14 54.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.367 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.46 -170.35 13.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -173.38 166.96 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -127.19 121.95 32.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -126.98 78.49 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 110.043 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.46 13.66 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.726 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.448 ' H ' ' C ' ' A' ' 8' ' ' DPR . 48.9 tttt -149.36 153.65 37.73 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.71 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 pp -147.45 141.63 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.238 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.43 130.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -169.83 174.8 5.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -144.43 -6.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.16 66.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.627 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.64 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -139.22 -132.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -145.23 129.86 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.542 ' H ' ' CA ' ' A' ' 14' ' ' ASN . . . 53.2 172.07 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -173.29 122.8 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -79.44 129.64 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.271 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -134.5 74.21 1.52 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.423 0.63 . . . . 0.0 110.034 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' DPR . . . . . 0.47 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.51 11.9 0.95 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.169 1.913 . . . . 0.0 112.626 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' PHE . 24.9 ttmt -160.76 154.13 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.429 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -146.86 145.07 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 22.2 mm -103.83 162.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.03 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.6 tpt180 -106.74 -29.76 9.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.967 0.413 . . . . 0.0 110.908 -179.725 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.636 HD21 ' N ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -127.23 -167.29 1.72 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.546 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLU . . . . . 0.636 ' N ' HD21 ' A' ' 14' ' ' ASN . 1.4 tm-20 -176.53 -179.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.578 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ARG . . . . . 0.47 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 41.6 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.552 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER 56.0 -166.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.695 0.283 . . . . 0.0 110.419 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 2' ' ' SER . 36.6 mtp180 55.48 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.519 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.53 117.71 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 6' ' ' ARG . 11.3 t80 173.52 125.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -56.83 134.21 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.867 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.54 71.16 1.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.413 0.625 . . . . 0.0 110.874 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.517 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 10.47 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.21 1.94 . . . . 0.0 112.11 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 12.4 tttp -165.34 149.07 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.462 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 11' ' ' ILE . 1.2 pp -143.62 131.47 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 mm -111.45 153.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.272 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -163.73 141.61 7.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 15' ' ' GLU . 15.5 m120 -164.54 -17.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.15 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ASN . 4.7 tp10 33.0 40.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.504 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 2' ' ' SER . 13.9 tpp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.398 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -164.63 78.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.608 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.557 HH11 ' CG2' ' A' ' 12' ' ' ILE . 9.2 ttp180 -172.26 125.62 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.567 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.12 176.81 35.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.423 ' CG ' ' N ' ' A' ' 6' ' ' ARG . 63.1 t80 -173.14 164.9 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 5' ' ' PHE . 17.0 ttm-85 -120.21 126.67 51.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.18 73.85 1.51 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.602 0.715 . . . . 0.0 110.485 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.458 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 11.64 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.259 1.972 . . . . 0.0 112.603 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -161.6 151.59 16.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.57 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.19 146.46 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.331 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CG2' HH11 ' A' ' 3' ' ' ARG . 22.3 mm -103.11 134.13 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.453 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 175.71 143.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.55 134.74 19.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.52 55.62 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.543 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.568 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -149.63 60.09 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.472 HH21 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mtt-85 -143.72 134.34 24.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.49 167.66 35.77 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -168.09 159.8 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 110.422 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 124.51 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.343 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -135.16 73.71 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.291 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.466 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.98 11.1 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.3 2.0 . . . . 0.0 112.564 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' PHE . 40.6 tttt -160.71 149.55 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -147.68 147.98 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.06 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -102.26 144.56 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -166.24 162.48 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.626 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.2 -174.24 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.45 -14.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.427 ' O ' ' O ' ' A' ' 1' ' ' GLY . 0.3 OUTLIER -52.95 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.532 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' GLY . 15.6 mtp180 -137.78 20.83 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 3' ' ' ARG . . . 56.65 159.11 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -173.0 168.03 4.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.32 124.65 39.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.673 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 73.42 1.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.621 0.724 . . . . 0.0 110.642 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.469 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.27 9.31 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.189 1.926 . . . . 0.0 112.295 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.0 tttm -153.95 150.58 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.39 145.18 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.267 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 13' ' ' ARG . 29.4 mm -107.03 159.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.458 ' N ' HG22 ' A' ' 12' ' ' ILE . 2.8 tpt180 -132.11 -149.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 88.2 m-20 -148.16 144.63 27.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.931 179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ARG . 1.9 mt-10 -179.88 6.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 15' ' ' GLU . 1.1 tpt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.633 ' C ' ' CA ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' SER . . . . . 1.411 ' CA ' ' N ' ' A' ' 2' ' ' SER 0.832 1.6 m -40.98 -123.85 0.0 OUTLIER 'General case' 2 CA--C 0.992 -20.492 1 CA-C-O 128.647 4.07 . . . . 0.0 119.715 163.677 . . . . . . . . 5 3 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -120.94 122.51 40.34 Favored 'General case' 0 C--N 1.328 -0.333 1 CA-C-N 108.069 -4.15 . . . . 0.0 110.093 -177.968 . . . . . . . . 4 4 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.7 120.19 0.8 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 6' ' ' ARG . 8.5 t80 168.4 124.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.671 0.272 . . . . 0.0 110.671 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -55.55 137.17 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -136.77 71.33 1.41 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.517 0.675 . . . . 0.0 110.837 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.478 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.04 9.99 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.303 2.002 . . . . 0.0 112.275 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.7 ttmt -161.37 151.16 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ILE . . . . . 0.581 ' C ' HD12 ' A' ' 11' ' ' ILE . 1.4 pp -139.8 130.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.182 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 13' ' ' ARG . 26.1 mm -106.73 161.29 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.9 ttm180 -164.89 143.17 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -144.67 -121.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -159.27 0.01 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.835 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 2.5 tpt180 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -136.42 25.86 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.72 0.295 . . . . 0.0 110.54 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.94 148.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.06 160.27 23.83 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE1' ' O ' ' A' ' 6' ' ' ARG . 73.2 t80 -147.17 157.75 43.71 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.725 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 9.6 ttm180 -116.32 138.8 51.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.016 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 72.83 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 110.466 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.459 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.65 12.48 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.098 1.865 . . . . 0.0 112.164 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' PHE . 15.7 tttm -153.56 151.44 29.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 0.0 110.667 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 143.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.96 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -134.16 112.95 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' CG ' ' N ' ' A' ' 14' ' ' ASN . 11.5 ttm180 -153.2 154.13 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.533 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -116.29 -168.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.381 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 57.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -63.15 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.7 0.286 . . . . 0.0 110.475 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.9 ttm180 -102.75 -25.65 13.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.161 0.505 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 3' ' ' ARG . . . 53.53 166.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -172.83 164.03 5.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 128.32 55.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.41 72.06 1.41 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.637 0.732 . . . . 0.0 110.573 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.46 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.98 10.94 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.234 1.956 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' PHE . 27.8 tttt -163.57 150.94 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 146.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -99.19 134.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 174.22 143.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.498 ' O ' ' N ' ' A' ' 16' ' ' ARG . 0.4 OUTLIER -162.99 128.2 3.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.477 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 5.2 mp0 41.66 -93.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' ASN . 14.5 ttm-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.545 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 78.0 39.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -136.99 143.5 42.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.581 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 -178.49 35.33 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE1' ' CE2' ' A' ' 7' ' ' PHE . 7.9 t80 -173.28 118.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.21 124.25 31.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' CE2' ' CE1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -133.34 75.74 1.63 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.195 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.465 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.03 11.0 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.217 1.945 . . . . 0.0 112.586 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 8' ' ' DPR . 34.8 tttt -155.88 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.05 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.265 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.11 136.8 44.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.206 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 176.28 143.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -127.07 -133.88 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -168.09 45.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.683 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -75.92 -123.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.729 0.3 . . . . 0.0 110.563 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -122.44 139.14 54.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.367 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.46 -170.35 13.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -173.38 166.96 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -127.19 121.95 32.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -126.98 78.49 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 110.043 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.46 13.66 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.726 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' PHE . 48.9 tttt -149.36 153.65 37.73 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.71 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 pp -147.45 141.63 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.238 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.43 130.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -169.83 174.8 5.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -144.43 -6.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.16 66.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.627 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.64 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -139.22 -132.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -145.23 129.86 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.601 ' H ' ' CA ' ' A' ' 14' ' ' ASN . . . 53.2 172.07 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -173.29 122.8 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -79.44 129.64 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.271 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -134.5 74.21 1.52 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.423 0.63 . . . . 0.0 110.034 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' DPR . . . . . 0.47 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.51 11.9 0.95 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.169 1.913 . . . . 0.0 112.626 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' PHE . 24.9 ttmt -160.76 154.13 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.429 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -146.86 145.07 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 14' ' ' ASN . 22.2 mm -103.83 162.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.03 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' N ' HG22 ' A' ' 12' ' ' ILE . 1.6 tpt180 -106.74 -29.76 9.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.967 0.413 . . . . 0.0 110.908 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.601 ' CA ' ' H ' ' A' ' 4' ' ' GLY . 6.0 p30 -127.23 -167.29 1.72 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.546 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLU . . . . . 0.467 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 1.4 tm-20 -176.53 -179.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.578 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 41.6 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.552 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.713 0 N-CA-C 110.851 -0.9 . . . . 0.0 110.851 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.483 ' H ' ' C ' ' A' ' 16' ' ' ARG . 0.1 OUTLIER 56.0 -166.57 0.11 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.695 0.283 . . . . 0.0 110.419 -179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.412 ' O ' ' O ' ' A' ' 2' ' ' SER . 36.6 mtp180 55.48 109.0 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.326 -0.397 . . . . 0.0 110.519 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 176.53 117.71 0.51 Allowed Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.874 -0.89 . . . . 0.0 110.874 179.957 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.52 ' CZ ' ' O ' ' A' ' 6' ' ' ARG . 11.3 t80 173.52 125.44 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.763 0.316 . . . . 0.0 110.697 179.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.52 ' O ' ' CZ ' ' A' ' 5' ' ' PHE . 0.0 OUTLIER -56.83 134.21 55.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.257 -0.429 . . . . 0.0 109.867 179.565 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.54 71.16 1.4 Allowed 'General case' 0 CA--C 1.533 0.301 0 CA-C-O 121.413 0.625 . . . . 0.0 110.874 -179.789 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.517 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 39.4 Cg_endo -69.34 10.47 0.43 Allowed 'Trans proline' 0 N--CA 1.493 1.455 0 C-N-CA 122.21 1.94 . . . . 0.0 112.11 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 12.4 tttp -165.34 149.07 8.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.462 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.613 ' C ' HD12 ' A' ' 11' ' ' ILE . 1.2 pp -143.62 131.47 18.42 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 115.701 -0.681 . . . . 0.0 109.935 179.653 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 29.0 mm -111.45 153.04 13.25 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.272 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 4.4 ptt-85 -163.73 141.61 7.45 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.986 0.422 . . . . 0.0 110.914 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.411 ' O ' ' C ' ' A' ' 15' ' ' GLU . 15.5 m120 -164.54 -17.98 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.15 179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.411 ' C ' ' O ' ' A' ' 14' ' ' ASN . 4.7 tp10 33.0 40.28 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.357 -0.838 . . . . 0.0 111.504 179.677 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.483 ' C ' ' H ' ' A' ' 2' ' ' SER . 13.9 tpp180 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.398 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 1.6 p -164.63 78.61 0.35 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.747 0.308 . . . . 0.0 110.608 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.557 HH11 ' CG2' ' A' ' 12' ' ' ILE . 9.2 ttp180 -172.26 125.62 0.53 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.225 -0.443 . . . . 0.0 110.567 179.975 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -158.12 176.81 35.06 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 -179.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.423 ' CG ' ' N ' ' A' ' 6' ' ' ARG . 63.1 t80 -173.14 164.9 4.88 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 110.142 -0.318 . . . . 0.0 110.142 -179.961 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.423 ' N ' ' CG ' ' A' ' 5' ' ' PHE . 17.0 ttm-85 -120.21 126.67 51.22 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.27 -0.423 . . . . 0.0 109.884 179.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.501 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.18 73.85 1.51 Allowed 'General case' 0 CA--C 1.534 0.338 0 CA-C-O 121.602 0.715 . . . . 0.0 110.485 -179.72 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.458 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -72.57 11.64 0.79 Allowed 'Trans proline' 0 N--CA 1.495 1.569 0 C-N-CA 122.259 1.972 . . . . 0.0 112.603 -179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.501 ' O ' ' N ' ' A' ' 7' ' ' PHE . 0.6 OUTLIER -161.6 151.59 16.99 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.827 0.346 . . . . 0.0 110.57 -179.91 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.19 146.46 19.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.331 179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.557 ' CG2' HH11 ' A' ' 3' ' ' ARG . 22.3 mm -103.11 134.13 45.05 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.453 -179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 19.0 ttt180 175.71 143.08 0.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.502 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.55 134.74 19.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.504 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -80.52 55.62 2.36 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.543 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 . . . . . 0 C--N 1.328 -0.327 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.568 179.999 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.523 0.59 0 N-CA-C 110.92 -0.872 . . . . 0.0 110.92 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 49.0 m -149.63 60.09 1.01 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.845 0.355 . . . . 0.0 110.613 -179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.472 HH21 ' CG ' ' A' ' 3' ' ' ARG . 4.9 mtt-85 -143.72 134.34 24.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.145 -0.48 . . . . 0.0 110.576 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -160.49 167.66 35.77 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 12.5 t80 -168.09 159.8 11.38 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.698 0.285 . . . . 0.0 110.422 179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.42 124.51 51.34 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.343 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.537 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.2 OUTLIER -135.16 73.71 1.49 Allowed 'General case' 0 CA--C 1.533 0.321 0 CA-C-O 121.589 0.709 . . . . 0.0 110.291 179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.466 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -72.98 11.1 0.94 Allowed 'Trans proline' 0 N--CA 1.493 1.49 0 C-N-CA 122.3 2.0 . . . . 0.0 112.564 -179.891 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.537 ' O ' ' N ' ' A' ' 7' ' ' PHE . 40.6 tttt -160.71 149.55 16.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.005 0.431 . . . . 0.0 110.707 -179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -147.68 147.98 16.8 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 115.522 -0.763 . . . . 0.0 110.06 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 20.8 mm -102.26 144.56 13.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.353 179.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 2.0 ptm180 -166.24 162.48 17.44 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.626 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -138.2 -174.24 3.75 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.527 -179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -138.45 -14.93 1.26 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.563 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 42.5 ttm-85 . . . . . 0 C--N 1.331 -0.199 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.564 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.427 ' O ' ' O ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.691 0 N-CA-C 111.032 -0.827 . . . . 0.0 111.032 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.475 ' C ' ' ND2' ' A' ' 14' ' ' ASN . 0.3 OUTLIER -52.95 -170.82 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.754 0.311 . . . . 0.0 110.532 179.963 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.705 ' N ' HD21 ' A' ' 14' ' ' ASN . 15.6 mtp180 -137.78 20.83 2.87 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.722 179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' N ' HD21 ' A' ' 14' ' ' ASN . . . 56.65 159.11 0.01 OUTLIER Glycine 0 CA--C 1.525 0.704 0 N-CA-C 110.692 -0.963 . . . . 0.0 110.692 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -173.0 168.03 4.91 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.754 0.311 . . . . 0.0 110.748 -179.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -127.32 124.65 39.21 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.673 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.53 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 73.42 1.49 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-O 121.621 0.724 . . . . 0.0 110.642 -179.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.469 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.9 Cg_endo -72.27 9.31 1.19 Allowed 'Trans proline' 0 N--CA 1.494 1.535 0 C-N-CA 122.189 1.926 . . . . 0.0 112.295 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.53 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.0 tttm -153.95 150.58 28.47 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.287 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.39 145.18 19.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.267 179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.458 HG22 ' N ' ' A' ' 13' ' ' ARG . 29.4 mm -107.03 159.22 6.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.042 -0.526 . . . . 0.0 110.136 179.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.526 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 2.8 tpt180 -132.11 -149.02 0.37 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.273 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.705 HD21 ' N ' ' A' ' 3' ' ' ARG . 15.8 m120 -148.16 144.63 27.9 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.019 0.438 . . . . 0.0 110.931 179.911 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.418 ' H ' ' H ' ' A' ' 16' ' ' ARG . 1.9 mt-10 -179.88 6.39 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.132 179.999 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.418 ' H ' ' H ' ' A' ' 15' ' ' GLU . 1.1 tpt85 . . . . . 0 C--N 1.33 -0.275 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.454 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.633 ' C ' ' CA ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.703 0 N-CA-C 110.734 -0.946 . . . . 0.0 110.734 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 1.411 ' CA ' ' N ' ' A' ' 2' ' ' SER 0.832 1.6 m -40.98 -123.85 0.0 OUTLIER 'General case' 2 CA--C 0.992 -20.492 1 CA-C-O 128.647 4.07 . . . . 0.0 119.715 163.677 . . . . . . . . 5 3 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.53 ' O ' ' ND2' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -120.94 122.51 40.34 Favored 'General case' 0 C--N 1.328 -0.333 1 CA-C-N 108.069 -4.15 . . . . 0.0 110.093 -177.968 . . . . . . . . 4 4 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -172.7 120.19 0.8 Allowed Glycine 0 CA--C 1.524 0.623 0 N-CA-C 110.623 -0.991 . . . . 0.0 110.623 -179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.528 ' CE2' ' O ' ' A' ' 6' ' ' ARG . 8.5 t80 168.4 124.28 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 120.671 0.272 . . . . 0.0 110.671 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.528 ' O ' ' CE2' ' A' ' 5' ' ' PHE . 0.4 OUTLIER -55.55 137.17 49.36 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 179.47 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.542 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -136.77 71.33 1.41 Allowed 'General case' 0 CA--C 1.533 0.298 0 CA-C-O 121.517 0.675 . . . . 0.0 110.837 -179.746 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.478 ' C ' ' H ' ' A' ' 10' ' ' LYS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -71.04 9.99 0.73 Allowed 'Trans proline' 0 N--CA 1.493 1.493 0 C-N-CA 122.303 2.002 . . . . 0.0 112.275 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.542 ' O ' ' N ' ' A' ' 7' ' ' PHE . 3.7 ttmt -161.37 151.16 16.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.216 -0.447 . . . . 0.0 110.443 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . 0.581 ' C ' HD12 ' A' ' 11' ' ' ILE . 1.4 pp -139.8 130.52 31.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.182 179.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 13' ' ' ARG . 26.1 mm -106.73 161.29 5.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.045 179.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.463 ' N ' HG22 ' A' ' 12' ' ' ILE . 15.9 ttm180 -164.89 143.17 6.49 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.65 -179.761 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.533 HD22 ' N ' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -144.67 -121.44 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.415 179.85 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -159.27 0.01 0.08 Allowed 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.835 -179.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.419 ' O ' ' OD1' ' A' ' 14' ' ' ASN . 2.5 tpt180 . . . . . 0 C--N 1.33 -0.257 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.833 -179.837 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.625 0 N-CA-C 110.99 -0.844 . . . . 0.0 110.99 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.491 ' N ' ' OD1' ' A' ' 14' ' ' ASN . 0.7 OUTLIER -136.42 25.86 3.17 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.72 0.295 . . . . 0.0 110.54 -179.978 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 3.9 mtp85 61.94 148.42 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.678 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -133.06 160.27 23.83 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.865 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.521 ' CE1' ' O ' ' A' ' 6' ' ' ARG . 73.2 t80 -147.17 157.75 43.71 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 120.811 -0.356 . . . . 0.0 110.725 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . 0.521 ' O ' ' CE1' ' A' ' 5' ' ' PHE . 9.6 ttm180 -116.32 138.8 51.03 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.016 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.515 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -134.27 72.83 1.47 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 121.595 0.712 . . . . 0.0 110.466 -179.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.459 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -74.65 12.48 1.13 Allowed 'Trans proline' 0 N--CA 1.493 1.482 0 C-N-CA 122.098 1.865 . . . . 0.0 112.164 179.755 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.515 ' O ' ' N ' ' A' ' 7' ' ' PHE . 15.7 tttm -153.56 151.44 29.77 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.948 0.404 . . . . 0.0 110.667 -179.782 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 143.7 20.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.695 -0.684 . . . . 0.0 109.96 179.458 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.897 HD12 ' H ' ' A' ' 12' ' ' ILE . 0.0 OUTLIER -134.16 112.95 16.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.643 -179.878 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.404 ' CG ' ' N ' ' A' ' 14' ' ' ASN . 11.5 ttm180 -153.2 154.13 34.1 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.533 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.727 ' ND2' ' H ' ' A' ' 14' ' ' ASN . 0.0 OUTLIER -116.29 -168.82 1.5 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.381 -179.918 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 -72.27 57.09 0.36 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.411 179.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 5.7 ttt85 . . . . . 0 C--N 1.329 -0.322 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.536 179.965 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.452 ' N ' ' CG ' ' A' ' 16' ' ' ARG . . . . . . . . 0 CA--C 1.524 0.63 0 N-CA-C 110.841 -0.904 . . . . 0.0 110.841 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.468 ' CB ' HD21 ' A' ' 14' ' ' ASN . 0.3 OUTLIER -63.15 -169.05 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.7 0.286 . . . . 0.0 110.475 179.966 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . 0.426 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.9 ttm180 -102.75 -25.65 13.45 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.161 0.505 . . . . 0.0 110.285 179.939 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.426 ' O ' ' O ' ' A' ' 3' ' ' ARG . . . 53.53 166.47 0.02 OUTLIER Glycine 0 CA--C 1.524 0.633 0 N-CA-C 110.863 -0.895 . . . . 0.0 110.863 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 49.9 t80 -172.83 164.03 5.09 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.775 0.321 . . . . 0.0 110.732 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.14 128.32 55.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.92 179.651 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.556 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.1 OUTLIER -137.41 72.06 1.41 Allowed 'General case' 0 CA--C 1.534 0.35 0 CA-C-O 121.637 0.732 . . . . 0.0 110.573 -179.656 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.46 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -71.98 10.94 0.77 Allowed 'Trans proline' 0 N--CA 1.493 1.461 0 C-N-CA 122.234 1.956 . . . . 0.0 112.453 -179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.556 ' O ' ' N ' ' A' ' 7' ' ' PHE . 27.8 tttt -163.57 150.94 12.59 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.843 0.354 . . . . 0.0 110.366 179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.5 pp -146.86 146.15 18.88 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-N 115.808 -0.633 . . . . 0.0 110.208 179.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 23.5 mm -99.19 134.46 38.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.338 179.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 7.1 ttp180 174.22 143.1 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.321 -179.889 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.593 ' N ' ' ND2' ' A' ' 14' ' ' ASN . 0.1 OUTLIER -162.99 128.2 3.15 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.477 -179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.42 ' CD ' ' N ' ' A' ' 15' ' ' GLU . 5.2 mp0 41.66 -93.38 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.496 -179.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.498 ' N ' ' O ' ' A' ' 14' ' ' ASN . 14.5 ttm-85 . . . . . 0 C--N 1.33 -0.27 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.545 179.894 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.448 ' O ' ' CB ' ' A' ' 2' ' ' SER . . . . . . . . 0 CA--C 1.525 0.659 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . 0.448 ' CB ' ' O ' ' A' ' 1' ' ' GLY . 1.7 p 78.0 39.61 0.16 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.0 110.559 -179.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 49.5 mtt180 -136.99 143.5 42.82 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.581 -179.95 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -161.34 -178.49 35.33 Favored Glycine 0 CA--C 1.524 0.651 0 N-CA-C 110.84 -0.904 . . . . 0.0 110.84 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . 0.555 ' CE1' ' CE2' ' A' ' 7' ' ' PHE . 7.9 t80 -173.28 118.46 0.3 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.719 0.295 . . . . 0.0 110.386 -179.95 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -85.21 124.25 31.64 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.344 -0.389 . . . . 0.0 110.241 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.555 ' CE2' ' CE1' ' A' ' 5' ' ' PHE . 0.2 OUTLIER -133.34 75.74 1.63 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-O 121.364 0.602 . . . . 0.0 110.195 179.977 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.465 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -72.03 11.0 0.77 Allowed 'Trans proline' 0 N--CA 1.494 1.505 0 C-N-CA 122.217 1.945 . . . . 0.0 112.586 -179.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.444 ' H ' ' C ' ' A' ' 8' ' ' DPR . 34.8 tttt -155.88 150.8 26.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.893 0.378 . . . . 0.0 110.484 179.985 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -147.05 139.86 19.34 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.265 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.0 mm -110.11 136.8 44.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.206 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 14.5 ttt85 176.28 143.5 0.07 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.534 -179.947 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.8 m-20 -127.07 -133.88 0.24 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.392 179.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 27.8 tt0 -168.09 45.53 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.683 179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.532 179.939 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.525 0.672 0 N-CA-C 110.897 -0.881 . . . . 0.0 110.897 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 19.3 m -75.92 -123.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.729 0.3 . . . . 0.0 110.563 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 10.5 mtt-85 -122.44 139.14 54.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.367 179.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -144.46 -170.35 13.7 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 -179.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -173.38 166.96 4.77 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 110.124 -0.325 . . . . 0.0 110.124 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 11.3 ttm-85 -127.19 121.95 32.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.265 -179.888 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.473 ' O ' ' C ' ' A' ' 8' ' ' DPR . 0.2 OUTLIER -126.98 78.49 1.81 Allowed 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 121.187 0.517 . . . . 0.0 110.043 179.71 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.473 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -74.46 13.66 0.88 Allowed 'Trans proline' 0 N--CA 1.494 1.537 0 C-N-CA 122.207 1.938 . . . . 0.0 112.726 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.41 ' N ' ' O ' ' A' ' 7' ' ' PHE . 48.9 tttt -149.36 153.65 37.73 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.71 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.7 pp -147.45 141.63 19.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.728 -0.669 . . . . 0.0 110.238 179.557 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . . . . . . . . . 28.5 mm -110.43 130.95 62.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.197 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.555 -179.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . . . . . . . . . 1.1 ptt180 -169.83 174.8 5.49 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.583 179.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -144.43 -6.27 0.72 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.546 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 59.16 66.54 1.03 Allowed 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.552 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . . . . . . . . . 1.6 tpm_? . . . . . 0 C--N 1.329 -0.315 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.627 -179.924 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.524 0.64 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' SER . . . . . . . . . . . . . 18.4 m -139.22 -132.35 0.12 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.764 0.316 . . . . 0.0 110.621 179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ARG . . . . . . . . . . . . . 36.9 mtm180 -145.23 129.86 18.02 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.585 179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.601 ' H ' ' CA ' ' A' ' 14' ' ' ASN . . . 53.2 172.07 0.04 OUTLIER Glycine 0 CA--C 1.524 0.608 0 N-CA-C 110.901 -0.88 . . . . 0.0 110.901 179.993 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' PHE . . . . . . . . . . . . . 24.7 t80 -173.29 122.8 0.38 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.77 0.319 . . . . 0.0 110.543 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ARG . . . . . . . . . . . . . 17.1 ttp180 -79.44 129.64 34.66 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.271 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PHE . . . . . 0.539 ' N ' ' O ' ' A' ' 10' ' ' LYS . 0.3 OUTLIER -134.5 74.21 1.52 Allowed 'General case' 0 CA--C 1.533 0.318 0 CA-C-O 121.423 0.63 . . . . 0.0 110.034 179.855 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' DPR . . . . . 0.47 ' C ' ' O ' ' A' ' 7' ' ' PHE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -73.51 11.9 0.95 Allowed 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 122.169 1.913 . . . . 0.0 112.626 -179.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LYS . . . . . 0.539 ' O ' ' N ' ' A' ' 7' ' ' PHE . 24.9 ttmt -160.76 154.13 21.89 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.755 -0.378 . . . . 0.0 110.429 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ILE . . . . . . . . . . . . . 1.6 pp -146.86 145.07 19.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.411 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.178 179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ILE . . . . . 0.463 HG22 ' H ' ' A' ' 14' ' ' ASN . 22.2 mm -103.83 162.15 4.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.03 179.87 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ARG . . . . . 0.45 ' N ' HG22 ' A' ' 12' ' ' ILE . 1.6 tpt180 -106.74 -29.76 9.36 Favored 'General case' 0 C--N 1.332 -0.166 0 CA-C-O 120.967 0.413 . . . . 0.0 110.908 -179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.651 HD22 ' N ' ' A' ' 15' ' ' GLU . 0.9 OUTLIER -127.23 -167.29 1.72 Allowed 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.573 -0.74 . . . . 0.0 110.546 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLU . . . . . 0.651 ' N ' HD22 ' A' ' 14' ' ' ASN . 1.4 tm-20 -176.53 -179.9 1.08 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.578 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ARG . . . . . 0.454 ' H ' ' CD ' ' A' ' 15' ' ' GLU . 41.6 ttt180 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.552 -179.939 . . . . . . . . 1 1 . 1 stop_ save_